Crossmark

Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial

Crossref DOI link: https://doi.org/10.1186/s12885-022-10306-y

Published Online: 2022-11-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, Xi

Huang, Xiaodong

Luo, Jingwei

Xiao, Jianping

Wang, Kai

Qu, Yuan

Chen, Xuesong

Zhang, Ye

Wu, Runye

Wang, Jingbo

Zhang, Jianghu

Xu, Guozhen

Gao, Li

Liu, Shaoyan

Wang, Xiaolei

He, Xiaohui

Luo, Dehong

Yi, Junlin
Funding

Funding for this research was provided by:

Beijing Hope Run Special Fund of Cancer Foundation of China (LC2014L12)
License Information

Text and Data Mining valid from 2022-11-29

Version of Record valid from 2022-11-29
More Information

Article History

Received: 26 July 2022

Accepted: 10 November 2022

First Online: 29 November 2022

Declarations

:

: This study was performed in line with the principles of the 1964 Declaration of Helsinki. The study protocol was approved by the local ethics committee from the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (No. NCC3008). Informed consent was obtained from all subjects involved in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below